Optimisation of Stroke Prevention: Colchicine may be an option.

Secondary prevention encompasses the reduction of further stroke and TIA, any other vascular disease, cognitive decline and dementia, mood disturbances and poor quality of life. Tailored secondary prevention applies to almost all patients with stroke or TIA and can reduce stroke recurrence by 80%. Unfortunately, the risk of recurrent stroke remains elevated at 2.5-4% per year in patients treated with high doses of statin and antiplatelet therapies after stroke and TIA. (2) especially in those with cervical or intracranial large artery atherosclerosis. (2).